What they were paid
LEXICON PHARMACEUTICALS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $55,516 | $55,815 | $0 | $171,331 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LEXICON PHARMACEUTICALS, INC. DEF 14A filed March 16, 2026, accession 0001062822-26-000056, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025LEXICON PHARMACEUTICALS pays directors a $50,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit
The rest of the LEXICON PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Christopher J. Sobecki | Independent Director | $161,331 |
| Diane E. Sullivan | Independent Director | $171,331 |
| Judith L. Swain, M.D | Independent Director | $173,831 |
| Michael S. Exton, Ph.D | Director | $0 |
| Philippe J. Amouyal | Independent Director | $176,331 |
| Raymond Debbane | Chair of the Board | $196,331 |
| Samuel L. Barker, Ph.D | Independent Director | $188,831 |
The full LEXICON PHARMACEUTICALS compensation record
free company briefThis page is one director within LEXICON PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat